ACM meeting #22, 6-7 August 2020

The meeting of the Advisory Committee on Medicines (ACM).

The committee's advice was sought on 8 applications under evaluation by the TGA. The applications included:

• three for the registration of a new chemical entity
• one for the registration of a new combination of active ingredients
• two seeking extension of indications
• two seeking major variations to the dose or form of a product

The committee also considered information on whether there is a causal association between increasing rates of antidepressant dispensing on the Pharmaceutical Benefits Scheme and rates of youth suicide in Australia.

Members

Membership comprises of professionals with specific scientific, medical or clinical expertise, as well as appropriate consumer health issues relating to medicines.